163 related articles for article (PubMed ID: 14715879)
1. Inhibition of nuclear factor-kappaB cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cells.
Starenki D; Namba H; Saenko V; Ohtsuru A; Yamashita S
J Clin Endocrinol Metab; 2004 Jan; 89(1):410-8. PubMed ID: 14715879
[TBL] [Abstract][Full Text] [Related]
2. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
[TBL] [Abstract][Full Text] [Related]
4. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
[TBL] [Abstract][Full Text] [Related]
5. Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Starenki DV; Namba H; Saenko VA; Ohtsuru A; Maeda S; Umezawa K; Yamashita S
Clin Cancer Res; 2004 Oct; 10(20):6821-9. PubMed ID: 15501958
[TBL] [Abstract][Full Text] [Related]
6. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
Veuger SJ; Durkacz BW
DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
[TBL] [Abstract][Full Text] [Related]
7. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation.
Cusack JC; Liu R; Baldwin AS
Cancer Res; 2000 May; 60(9):2323-30. PubMed ID: 10811101
[TBL] [Abstract][Full Text] [Related]
8. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
9. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB inhibition radiosensitizes Ki-Ras-transformed cells to ionizing radiation.
Kim BY; Kim KA; Kwon O; Kim SO; Kim MS; Kim BS; Oh WK; Kim GD; Jung M; Ahn JS
Carcinogenesis; 2005 Aug; 26(8):1395-403. PubMed ID: 15802300
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor.
Hansson A; Marín YE; Suh J; Rabson AB; Chen S; Huberman E; Chang RL; Conney AH; Zheng X
Int J Oncol; 2005 Oct; 27(4):941-8. PubMed ID: 16142309
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of IkappaBalpha nuclear export as an approach to abrogate nuclear factor-kappaB-dependent cancer cell survival.
O'Connor S; Shumway S; Miyamoto S
Mol Cancer Res; 2005 Jan; 3(1):42-9. PubMed ID: 15671248
[TBL] [Abstract][Full Text] [Related]
13. Mercuric ion attenuates nuclear factor-kappaB activation and DNA binding in normal rat kidney epithelial cells: implications for mercury-induced nephrotoxicity.
Dieguez-Acuña FJ; Ellis ME; Kushleika J; Woods JS
Toxicol Appl Pharmacol; 2001 Jun; 173(3):176-87. PubMed ID: 11437639
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas.
Pacifico F; Mauro C; Barone C; Crescenzi E; Mellone S; Monaco M; Chiappetta G; Terrazzano G; Liguoro D; Vito P; Consiglio E; Formisano S; Leonardi A
J Biol Chem; 2004 Dec; 279(52):54610-9. PubMed ID: 15475567
[TBL] [Abstract][Full Text] [Related]
15. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells.
Ahmad N; Gupta S; Mukhtar H
Arch Biochem Biophys; 2000 Apr; 376(2):338-46. PubMed ID: 10775421
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-kappaB translocation mediates double-stranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL).
Robbins MA; Maksumova L; Pocock E; Chantler JK
Endocrinology; 2003 Oct; 144(10):4616-25. PubMed ID: 12960048
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
18. Cellular origin of ionizing radiation-induced NF-kappaB activation in vivo and role of NF-kappaB in ionizing radiation-induced lymphocyte apoptosis.
Meng A; Yu T; Chen G; Brown SA; Wang Y; Thompson JS; Zhou D
Int J Radiat Biol; 2003 Nov; 79(11):849-61. PubMed ID: 14698954
[TBL] [Abstract][Full Text] [Related]
19. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
Lenert P; Stunz L; YI AK; Krieg AM; Ashman RF
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):247-56. PubMed ID: 11572601
[TBL] [Abstract][Full Text] [Related]
20. BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activation.
Palona I; Namba H; Mitsutake N; Starenki D; Podtcheko A; Sedliarou I; Ohtsuru A; Saenko V; Nagayama Y; Umezawa K; Yamashita S
Endocrinology; 2006 Dec; 147(12):5699-707. PubMed ID: 16959844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
